ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone
Crossref DOI link: https://doi.org/10.1245/s10434-020-08634-z
Published Online: 2020-05-21
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mamtani, Anita
Morrow, Monica
Text and Data Mining valid from 2020-05-21
Version of Record valid from 2020-05-21
Article History
Received: 27 April 2020
First Online: 21 May 2020
Disclosure
: Dr. Monica Morrow has received honoraria from Genomic Health. Anita Mamtani has nothing to disclose.